Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New morphinoid delta-opioid ligands from SmithKline Beecham

Sep. 29, 1997

Naramig safe and effective for acute treatment of migraine

Sep. 26, 1997

Guilford reports interim preclinical results with neurotrophic agent

Sep. 26, 1997

New indication for lamotrigine tested in patients: ADHD

Sep. 26, 1997

Metrifonate efficacy in AD demonstrated in clinical trial

Sep. 26, 1997

4030W92 preclinical activity and structure reported at Barcelona congress

Sep. 26, 1997

Entacapone clinical and preclinical data reported at neurology congress

Sep. 26, 1997

News flash: new indication investigated for SR-57746A

Sep. 26, 1997

HMR presents 5-HT3 antagonists for CNS disorders

Sep. 26, 1997

Melatonin for treatment of fibromyalgia syndrome

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...